Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth A Conner

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Gastroenterology|December 20, 2011
Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitorsJesper B Andersen, Bart Spee, Boris R Blechacz, et al.
Hepatology (Baltimore, Md.)|May 28, 2011
Human hepatic cancer stem cells are characterized by common stemness traits and diverse oncogenic pathwaysJens U Marquardt, Chiara Raggi, Jesper B Andersen, et al.
Genes & Development|August 6, 2013
Specific fate decisions in adult hepatic progenitor cells driven by MET and EGFR signalingMitsuteru Kitade, Valentina M Factor, Jesper B Andersen, et al.
Journal for Immunotherapy of Cancer|July 6, 2022
Spatial meta-transcriptomics reveal associations of intratumor bacteria burden with lung cancer cells showing a distinct oncogenic signatureAbigail Wong-Rolle, Qiang Dong, Yunhua Zhu, et al.
Toxicology|July 11, 2016
Loss of c-Met signaling sensitizes hepatocytes to lipotoxicity and induces cholestatic liver damage by aggravating oxidative stressLuis E Gomez-Quiroz, Daekwan Seo, Yun-Han Lee, et al.
Journal of Hepatology|May 5, 2015
Curcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancerJens U Marquardt, Luis Gomez-Quiroz, Lucrecia O Arreguin Camacho, et al.
Cancer Research|June 25, 2014
Antitumor effects in hepatocarcinoma of isoform-selective inhibition of HDAC2Yun-Han Lee, Daekwan Seo, Kyung-Ju Choi, et al.
Hepatology (Baltimore, Md.)|February 5, 2016
Oncogenic driver genes and the inflammatory microenvironment dictate liver tumor phenotypeMatthias S Matter, Jens U Marquardt, Jesper B Andersen, et al.
Molecular Cancer Research : MCR|August 8, 2018
Integrated Genomic Comparison of Mouse Models Reveals Their Clinical Resemblance to Human Liver CancerSun Young Yim, Jae-Jun Shim, Ji-Hyun Shin, et al.
Cancer Research|October 21, 2010
Definition of ubiquitination modulator COP1 as a novel therapeutic target in human hepatocellular carcinomaYun-Han Lee, Jesper B Andersen, Ho-Taek Song, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Gastroenterology|December 20, 2011
Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitorsJesper B Andersen, Bart Spee, Boris R Blechacz, et al.
Hepatology (Baltimore, Md.)|May 28, 2011
Human hepatic cancer stem cells are characterized by common stemness traits and diverse oncogenic pathwaysJens U Marquardt, Chiara Raggi, Jesper B Andersen, et al.
Genes & Development|August 6, 2013
Specific fate decisions in adult hepatic progenitor cells driven by MET and EGFR signalingMitsuteru Kitade, Valentina M Factor, Jesper B Andersen, et al.
Journal for Immunotherapy of Cancer|July 6, 2022
Spatial meta-transcriptomics reveal associations of intratumor bacteria burden with lung cancer cells showing a distinct oncogenic signatureAbigail Wong-Rolle, Qiang Dong, Yunhua Zhu, et al.
Toxicology|July 11, 2016
Loss of c-Met signaling sensitizes hepatocytes to lipotoxicity and induces cholestatic liver damage by aggravating oxidative stressLuis E Gomez-Quiroz, Daekwan Seo, Yun-Han Lee, et al.
Journal of Hepatology|May 5, 2015
Curcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancerJens U Marquardt, Luis Gomez-Quiroz, Lucrecia O Arreguin Camacho, et al.
Cancer Research|June 25, 2014
Antitumor effects in hepatocarcinoma of isoform-selective inhibition of HDAC2Yun-Han Lee, Daekwan Seo, Kyung-Ju Choi, et al.
Hepatology (Baltimore, Md.)|February 5, 2016
Oncogenic driver genes and the inflammatory microenvironment dictate liver tumor phenotypeMatthias S Matter, Jens U Marquardt, Jesper B Andersen, et al.
Molecular Cancer Research : MCR|August 8, 2018
Integrated Genomic Comparison of Mouse Models Reveals Their Clinical Resemblance to Human Liver CancerSun Young Yim, Jae-Jun Shim, Ji-Hyun Shin, et al.
Cancer Research|October 21, 2010
Definition of ubiquitination modulator COP1 as a novel therapeutic target in human hepatocellular carcinomaYun-Han Lee, Jesper B Andersen, Ho-Taek Song, et al.
Pageof 5